R. Kent Jr McGaughy - 03 Mar 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director, 10%+ Owner
Signature
/s/ R. Kent McGaughy, Jr.
Issuer symbol
RETA
Transactions as of
03 Mar 2023
Transactions value $
$0
Form type
4
Filing time
07 Mar 2023, 15:37:08 UTC
Previous filing
30 Dec 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Gift $0 -33.2K -100% $0.00* 0 03 Mar 2023 See footnote F1, F5
holding RETA Class A common stock 25K 03 Mar 2023 Direct
holding RETA Class A common stock 2.9M 03 Mar 2023 See footnote F2, F5
holding RETA Class A common stock 4.59K 03 Mar 2023 By Lagos Trust F3, F5
holding RETA Class A common stock 280 03 Mar 2023 By Traweek Children's Trust F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Class A common stock are held in escrow for a charitable donee by American Stock Transfer & Trust Company, LLC.
F2 These shares of Class A common stock are held in various funds for which CPMG, Inc. serves as investment manager. Each of the Reporting Person and Antal Desai is a shareholder and managing partner of CPMG, Inc.
F3 The Reporting Person is trustee of Lagos Trust.
F4 The Reporting Person is trustee of Traweek Children's Trust.
F5 The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.